Mehta, Priya, Vipulkumar Thummar, and Harsh Bhavsar. “Clinical Outcomes of Neoadjuvant Dual HER2 Blockade With pertuzumab/Sigrima and trastuzumab/Vivitra Biosimilars: Real-World Evidence in HER2-Positive Breast Cancer in India”. International Journal of Research in Medical Sciences 14, no. 4 (March 30, 2026): 1584–1588. Accessed April 7, 2026. https://www.msjonline.org/index.php/ijrms/article/view/16637.